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Introduction. Lactobacillus casei and Lactobacillus acidophilus were used to assess the anti-inﬂammatory properties in carrageenan
induced acute inﬂammatory model. Materials and Methods. Diclofenac sodium was used as standard drug at concentration of
1 5 0m g / k go fb o d yw e i g h t .C u l t u r eo fLactobacillus 2 × 107 CFU/ml was given orally. Edema was induced with 1% carrageenan
to all the groups after one hour of the oral treatments. Paw thickness was checked at t = 1, 2, 3, 4, 5, and 24 hours. Stair
climbing score and motility score were assessed at t = 24 hours. Cytokines assay for IL-6, IL-10, and TNF-α was performed
on serum samples. Results. Lactobacillus showed a statistically signiﬁcant decrease in paw thickness at P<0.001. L. acidophilus
and L. casei decreased by 32% and 28% in paw thickness. They both signiﬁcantly increased the stair climbing and motility score.
Lactobacillus treatment signiﬁcantly downregulated IL-6 and TNF-α while upregulated IL-10 at P<0.0001. Conclusion. L. casei
and L. acidophilus signiﬁcantly decreased the inﬂammatory reactions induced by carrageenan. This study has also proposed that
Lactobacillus ameliorated the inﬂammatory reaction by downregulating the proinﬂammatory cytokines pathway.
1.Introduction
Inﬂammation is a local response of living mammaliantissues
to injury. It is a body defense reaction in order to eliminate
or limit the spread of injurious agent [1]. There are various
componentstoaninﬂammatoryreactionthatcancontribute
to the associated symptoms and tissue injury. Edema, leuko-
cyte inﬁltration, and granuloma formation represent such
components of inﬂammation. Though, it is a defense mech-
anism. The complex events and mediators involved in the
inﬂammatory reaction can induce or aggravate many reac-
tions [2].
As it is well known, the probiotic bacteria are nonpatho
-genic and consumed as/with food since a long time. The
use of probiotic bacteria in dietary supplements or dietary
productsiswidelydocumentedintheliterature.Lactobacillus
and its important species like L. casei and L. acidophilus have
been used against many pathological and disease condi-
tions. Lactobacillus is known for its antimicrobial, antilipi-
demic,immunomodulatory,anticancerous,antidiabetic,and
antiarthritic properties [3–10]. Lactobacillus has been as-
sessed for its immunomodulatory properties in diﬀerent
experiments [11–15].
According to the WHO report, about 70–80% of the
world’s population rely on nonconventional medicine main-
ly from herbal sources in their primary health care [16, 17].
Especially, its demand is increasing day by day in developing
countries where the cost of consulting a physician and price
of medicine are beyond the limit of most people [18].
These drugs are anti-inﬂammatory and used to ease pain in
various conditions including: arthritis, muscle, and ligament
pains. Conventional drugs treatments are limited in their2 International Journal of Inﬂammation
eﬀectiveness in managing the incidence and outcome of
many inﬂammatory diseases. They also present a signiﬁcant
number of side eﬀects in patients [19].
With these facts taken into account, present study was
planned to ﬁnd out the possibility of anti-inﬂammatory
activity of L. casei and L. acidophilus using carrageenan-
induced acute inﬂammatory model.
2.MaterialsandMethods
2.1. Bacterial Cultures. Lactobacillus acidophilus (ATCC 314)
and Lactobacillus casei (ATCC 334) were purchased from
Hi Media, Navi Mumbai, India. Lyophilized culture was
streaked over de Mann Rogosa Sharpe Agar (MRS) at 37◦C
in anaerobic condition.
2.2. Drugs and Chemicals Used. Carrageenan was purchased
from Hi Media, Mumbai, India. Standard anti-inﬂammatory
drug diclofenac sodium was purchased from Recon, Ban-
galore, India. Cytokines assay kits were purchased from
Ray Biotech, Norcross GA, USA and DNA Bio, Hyderabad,
Andhra Pradesh, India.
2.3. Animals. 35 male Wistar rats (200gm each) were used
for the present study. They were fed with standard pellet
diet and water ad libitum. All animals were acclimatized for
at least one week before the experimental session. All the
experimental procedures were done following the guidelines
of the Institutional Animals Ethics Committee (IEAC).
2.4. Evaluation of Anti-Inﬂammatory Activity. For the anti-
inﬂammatory activity against the acute inﬂammation, ani-
mals were divided into ﬁve groups.
Group A (carrageenan control) did not receive any oral
treatment; Group B (control) received 500μL of distilled
w a t e r ;G r o u pCa n dG r o u pDr e c e i v e d2× 107 CFU/mL
of L. casei and L. acidophilus, respectively, suspended in
500μL of distilled water. Group E (positive control) animals
were administered with diclofenac sodium (150mg/Kg body
weight).
2.5. Carrageenan-Induced Acute Inﬂammatory Model. Anti-
inﬂammatory activity was measured using carrageenan-
induced rat paw edema assay [20, 21]. Edema was induced
by subplantar injection of 100μL of 1% freshly prepared
solution of carrageenan in distilled water into the right-
hind paws of each rat of all the groups except the group A.
Animals of group B/C, D/E were treated with the single dose
of vehicle, cultures, and drug, respectively; 30 minutes prior
to carrageenan injection. Paw thickness were measured just
before the carrageenan injection, that is, at “0 hour” and
then at 1, 2, 3, 4, and 24th hour after carrageenan injection.
Increase in paw thickness was measured as the diﬀerence in
paw thickness at “0 hour” and paw thickness at respective
hours.
2.6. Stair Climbing Activity Test. Overnight fasting animals
were trained for one week to climb a staircase with steps at
5, 10, and 15cm having water at the second and food at the
third step. Climbing ability of the rats in above groups was
scored 0 if the rats did not climb; 1, if the rats climbed onto
step 1; 2, if the rats climbed onto step 2; 3, if the rat could
climb all the three steps [22, 23].
2.7. Motility Test. The motility pattern of the rats was
observed for a period of 5 minutes and scored 0, if the rat
walked with diﬃculty and avoided touching the toes of the
inﬂamed paw to the ﬂoor; 1, if the rat walked with little
diﬃculty, but with toe touching the ﬂoor; 2, if the rat walked
easily [22, 23].
2.8. Sample Collection. After 24 hours, all animals were
sacriﬁced with cardiovascular bleeding with the help of
Di ethyl ether according to the guidelines of CPSCEA
committee. Blood was collected for the cytokines assay.
Blood samples were left to coagulate for room temperature
for 60 minutes and then centrifuged at 1500g for 15 minutes
andcrudeserumwaskeptinnewtubes.Serumwasharvested
a n ds t o r e da t−20◦C until use.
2.9. Cytokines Assay. IL-10 (anti-inﬂammatory cytokines)
and IL-6, TNF-α (proinﬂammatory cytokines) in picogram
per millilitre (pg/mL) were estimated with the help of ELISA
Reader (Lisa Plus, Germany). Serum samples were used. IL-6
and TNF-α (Ray Bio ) and IL-10 (DNA bio) ELISA kits were
used.Assayswereperformedaccordingtothemanufacturer’s
recommendations.
2.10. Statistical Analysis. The value for edema volume is
expressedasmean ±SEMofsevenobservationsandANOVA
followed by post hoc test. Duncans test was used to compare
the groups. The stair climbing ability test and motility are
expressed as median scores and the Kruskal-Wallis test was
used to compare the groups.
3. Results
3.1. Carrageenan-Induced Inﬂammation. Injection of car-
rageenan into the hind paw induced a progressive edema
reachingitsmaximumat4hours.IncaseofGroupAanimals
paw thickness found at t = 0w a s3 .023 ±0.0408cm and this
remains constant at the end of 24 hours. Group B animals
had showed an increase in paw thickness at each hour which
was signiﬁcant at P<0.001. At 0 hours the thickness was
3.028 ± 0.040cm, which increased to 3.59 ± 0.049cm at
t = 3 hours. At 24 hours the thickness was found to be
4.01 ± 0.025cm. The paw thickness of Group C animals was
3±0.028cm which showed a mild increase at the end of 2nd
hour,thatis,3.35±0.0102cm.Afterthe2ndhouritdecreased
to 3.04 ± 0.077cm, 3.014 ± 0.0489cm, 2.99 ± 0.0053cm,
and 3.014 ± 0.024cm at the end of 3, 4, 5, and 24 hours,
respectively. Group D animals showed an increase up to the
2nd hour. 3.03 ± 0.065cm thickness was found at the end of
third hour, which decreased to 3.0014 ± 0.0024cm at t = 24
hours.So,GroupsCandDindicatedastatisticallysigniﬁcant
decrease in paw thickness (P<0.001). Group E animals also
showedanincreaseinpawthicknessof3.042 ±0.077cm(t =
0h o u r s ) ,3 .26 ± 0.069cm (t = 1h o u r s ) ,3 .22 ± 0.0184cm
(t = 2h o u r s ) ,a n d3 .074 ± 0.0762cm (t = 3h o u r s ) .I t
increased after the third hour to 3.174 ± 0.057cm (t = 24International Journal of Inﬂammation 3
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Figure 1: Change in paw thickness (cm) at t = 0,1,2,3,4,5, and
24 hours. n = 5 (signiﬁcant at P<0.001). Edema was induced by
injecting 0.1mL of 1% solution of carrageenan into the sub plantar
surface of right-hind paw. Data are expressed as mean ± standard
error of seven rats per group. Group A: carrageenan control; Group
B: control; Group C: L. casei fed; Group D: L. acidophilus;G r o u pE :
positive control.
hours). These values were found to be statistically signiﬁcant
at P<0.001 (Figure 1).
3.2. Stair Climbing Activity. Hyperalgesia was induced by
carrageenan in Group B rats. Their stair climbing activity
was 0.28 ± 0.244, while highest score was observed in
Group A animals at 3 ± 0.00 (statistically signiﬁcant; P<
0.001). Lactobacillus treatment signiﬁcantly increased the
stair climbing score of 2.57 ± 0.489 and 2.71 ± 0.408 for
GroupCandGroupDrespectively(signiﬁcantatP<0.001).
Group E animals were showing a score of 1.71 ± 0.6122.
Group B animal score was lowest in comparison to Groups
A, C, D, and E animals (Figure 2).
3.3. Motility. Walking ability of the rats to climb the staircase
at the time of peak inﬂammation was checked by motility
score. Group C and Group D animals were showing the
highest score of 1.42 ± 0.489 (signiﬁcant at P<0.001). Score
for Group A animals was 2 ± 0.00 whereas 0.14 ± 0.244
was found in case of group B animals. This was found to be
the lowest when comparing Group E and Group B animals
(Figure 3).
3.4. Cytokine Assay. Serum levels of IL-6 and TNF-α were
highest in Group B animals, that is, 70.45 ± 0.266pg/mL
and 669.23 ±0.050pg/mL, respectively, while this group was
showing lowest value of IL-10 (14.15 ± 0.035pg/mL). On
the contrary, Lactobacillus treatment statistically decreased
the IL-6 and TNF-α i nG r o u pCa n dG r o u pDa tP<
0.0001. Lowest value for IL-6 was observed in case of Group
Da t4 4 .505 ± 0.198pg/mL, while lowest value of TNF-
α was observed for Group C at 420.77 ± 0.265pg/mL.
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Figure 2: Eﬀect of Lactobacillus on impairment in stair climb-
ing activity score associated carrageenan-induced inﬂammation.
Edema was induced by injecting 0.1mL of 1% solution of
carrageenan into subplantar surface of right-hind paw. The drugs
were administered subcutaneously 30 minutes before injecting
inﬂammagen. Stair climbing activity was observed at the time of
peak inﬂammation (4 hours for carrageenan). Data are expressed
as mean ± standard error of seven rats per group. Group A:
carrageenancontrol;GroupB:control;GroupC:L.caseifed;Group
D: L. acidophilus; Group E: positive control.
Table 1: Eﬀect of oral administration of L. casei and L. acidophilus
on cytokines expression (pg/mL).
Groups IL-6 TNF-α IL-10
Group A 54.42±0.193∗ 530.75±0.337∗ 25.075±0.047∗
Group B 70.45 ±0.266 669.23 ±0.050 14.15 ± 0.035
Group C 44.57±1.809∗ 420.77±0.265∗ 35.65 ±0.086∗
Group D 44.50±0.198∗ 425.77±0.187∗ 38.725±0.047∗
Group E 64.60±0.131∗ 490.52±0.228∗ 29.675±0.075∗
Dataareexpressedasmean ±standarderrorofsevenratspergroup ∗Values
alongcolumnsarestatisticallysigniﬁcantatP<0.0001whencomparedwith
Group B (control). Group A: carrageenan control; Group B: control; Group
C: L. casei fed; Group D: L. acidophilus; Group E: positive control.
Group E animals was showing IL-6, TNF-α, and IL-10
values of 64.60 ± 0.131pg/mL, 490.52 ± 0.228pg/mL, and
29.675 ± 0.075pg/mL, respectively. Only IL-6 concentration
for Group E animals was not signiﬁcant at P<0.0001
while IL-10 and TNF-α concentrations were signiﬁcant at
P<0.0001 (Table 1).
4. Discussion
Carrageenan-induced rat paw edema model is a suitable
test for evaluating anti-inﬂammatory drugs, which has
frequently been used to assess the antiedematous eﬀect of
the drug. Carrageenan is a strong chemical use for the
release of inﬂammatory and proinﬂammatory mediators
(prostaglandins, leukotrienes, histamine, bradykinin, TNF-
α,e t c . )[ 24].
The course of acute inﬂammation is biphasic. First
phase starts with the release of histamine, serotonin, and
kinins after the injection of phlogistic agent in the ﬁrst4 International Journal of Inﬂammation
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Figure 3: Eﬀect of various drugs on impairment in motility
associated with carrageenan-induced inﬂammation. Edema was
induced by injecting 0.1mL of 1% solution of carrageenan into
subplantar surface of right-hind paw. The drugs were administered
subcutaneously 30 minutes before injecting inﬂammagen. Motility
score was observed at the time of peak inﬂammation (4 hours for
carrageenan). Data are expressed as mean ± standard error of seven
rats per group. Group A: carrageenan control; Group B: control;
Group C: L. casei fed; Group D: L. acidophilus;G r o u pE :p o s i t i v e
control.
few hours [25]. While the second phase is related to the
releaseofprostaglandinslikesubstancesin2-3hours.Second
phase is sensitive to both the clinically useful steroidal and
nonsteroidal anti-inﬂammatory agent [26]. Prostaglandins
arethemainculprit responsible foracuteinﬂammation. Lac-
tobacillus sp might be containing some anti-inﬂammatory
agent which is responsible for the blockage of prostaglandins
and inﬂammatory pathway.
In this model of inﬂammation, L. casei and L. acidophilus
had very consistent anti-inﬂammatory activity and thus
showed signiﬁcant decrease in the paw thickness of rat
( G r o u pCa n dG r o u pD ) .P r e v i o u s l y ,s o m er e s e a r c h e r sh a v e
also proposed the anti-inﬂammatory property of Lacto-
bacillus in gut [27–29]. Although, the cyclooxygenase and
lipoxygenase pathways play a pivotal role in the inﬂam-
matory process, the inhibition of cyclooxygenase is more
eﬀective in inhibiting carrageenan-induced inﬂammation
than lipoxygenase inhibitors [30].
Lactobacillus might have inhibited the cyclooxygenase
that synthesizes prostaglandins. Oral administration of
Lactobacillus signiﬁcantly downregulated the proinﬂamma-
tory cytokines while upregulated the anti-inﬂammatory
cytokines. Prostaglandins play essential role in inﬂammation
[7]. Prostaglandins synthesis is down regulated by anti-
inﬂammatory cytokines like IL-10, IL-4 and IL-13, which
also check Coxygenase-2 synthesis. Coxygenase-2 is respon-
sible for the increased production of prostaglandins. And
hence, L. casei and L. acidophilus overcome the inﬂammation
induced by carrageenan. Our present ﬁndings are consis-
tent with the results of some other workers [7, 31–34].
Studies have shown that IL-10 has been found as a potent
macrophage deactivator, which blocked TNF-α, IL-1, IL-6,
IL-8, and GM-CSF by human monocytes [35].
Knowledge on the immune-mediated mechanisms in
metabolic scenario has markedly increased in the recent
past, evidencing the role that dietary components may have
to modulate immunity by enhancing or suppressing the
immune response. For instance, certain strains of probi-
o t i c sh a v eb e e nd e m o n s t r a t e dt ob ea b l et om o d u l a t et h e
immune system by stimulating release of diﬀerent patterns
of cytokines by diﬀerent cells. It could be able to modify
the number of CD4 T cells and actively interfere with anti-
inﬂammatory and proinﬂammatory signalling pathways by
inducing production of IL-10 and reducing INF-γ and TNF-
α release [36]. Probiotics modulate both innate and acquired
immunity by interacting with indigenous bacteria and/or
host mucosal cells to induce or modulate the immune
response.Thiscanbeanotherpossiblereasonbehinditsanti-
inﬂammatory property in this study.
The present results suggest that Lactobacillus suppresses
the ﬁrst phase of carrageenan-induced paw edema, thus,
conﬁrming an NSAID-like property. The present study
showed that L. casei and L. acidophilus have both analgesic
and anti-inﬂammatory properties.
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